Skip to main content
. 2013 Apr 4;24(5):744–758. doi: 10.1681/ASN.2012030295

Table 1.

Small molecule inhibitors of the cAMP-induced redistribution of AQP2.

No. ID Structure Formula Ratio Plate Well Molecular Weight Partition Coefficient H-Acc H-Don IUPAC Nomenclature
1 4-acetydiphillin (4AD) 216407 Inline graphic C23H18O8 0.88 115 N9 422.4 3.08 6 0 9-benzo[d][1,3] dioxol- 5-yl)-6,7-dimethoxy-1-oxo-1,3-dihydronaphtho[2,3-c]furan-4-yl acetate
2 212678 Inline graphic C23H24FN3O2S 0.84 105 K1 425.5 4.99 4 0 (8-ethyl-3-(4-fluorophenyl)-2-thioxo-1,4,8-triazaspiro[4.5]dec-3-en-1-yl)(4-methoxyphenyl)methanone
3 212634 Inline graphic C31H36N4O4S 0.88 104 D14 560.7 5.2 6 3 N-{2[benzyl (isopropyl)amino] ethyl}-6-[(4isopropylphenyl)sulfamoyl]-4-oxo-1H-quinoline-3-carboxamide
4 202336 Inline graphic C18H22N2O2 1 75 P11 298.4 1.69 3 3 3-((3-(9H-carbazol-9-yl) 2 hydroxypropyl)amino)propan-1-ol
5 209614 triazolpropenon Inline graphic C17H10Cl3N3O2 1.06 96 K6 394.6 4.58 4 1 (Z)-3-(3-chloro-6-hydroxycyclohexa-2,4-dienyl)-1-(2,4-dichlorophenyl)-2-(11H,2,4-triazol-1-yl)prop-2-en-1-one
6 214590 Inline graphic C23H20N4O2 0.69 110 K18 384.4 3.24 2 2 N-(naphthalen-1-yl)-4-(2-oxo-3H-1,3-benzodiazol-1-yl)-3,6-dihydro-2H-pyridine-1-carboxamide
7 205653 Inline graphic C24H18N2O7S2 0.78 85 I5 510.5 3.52 6 4 N,N′-bis(4-hydroxyphenyl)dibenzo[b,d]furan-2,8-disulfonamide
8 216086 Inline graphic C25H32N4O2 0.79 114 L17 420.5 3.47 4 1 N-{3-[ethyl(3-methylphenyl)amino]propyl}-2-[3-(4-methylphenyl)-6-oxo-4,5-dihydropyridazin-1-yl]acetamide
9 214645 Inline graphic C19H23N3 0.8 110 J9 293.4 3.62 2 1 9-cyclohexyl-2,3,5,6-tetrahydro-1H-3,4,6a-triazafluoranthene
10 203240 Inline graphic C13H18NS2 0.89 78 O17 252.4 1.6 0 0 2-cyclohexyl-5-ethyl-2,3-dihydrothieno[3,2-d]isothiazole
11 215223 Inline graphic C22H20BrNO4S 0.9 112 M21 474.4 4.23 3 1 5-[(4-bromobenzenesulfonyl)methyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)furan-2-carboxamide
12 203313 Inline graphic C17H21N3O3 1 78 A16 315.4 0.79 3 1 N-(3,5-dimethylphenyl)-2-(1,4 dioxohexahydropyrrolo[1,2-a] pyrazin-2(1H)-yl) acetamide
13 201213 Inline graphic C22H20N2O3 1.02 72 I18 360.4 4.47 5 1 N-(3,4,5-trimethoxyphenyl)acridin-9-amine
14 208677 Inline graphic C21H15N4O2S 1.07 93 J13 387.4 1.13 5 0 2-(1,3-benzothiazol-2-yl)-5-benzyl-4-methyl-3-oxo-3,5-dihydro-2H-pyrazolo[4,3-c]pyridin-6-olate
15 202329 Inline graphic C22H21ClN2O3S 1.12 75 B11 428.9 3.69 3 1 N-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)-N-(4-chlorophe nyl)methane-sulfonamide
16 204332 Inline graphic C18H19NO4 1.16 81 G6 313.3 3.84 4 1 3-[(3,4dimethyl-phenyl)amino]-6,7-dimethoxy-3H-2-benzofuran-1-one
17 209044 Inline graphic C20H15NO5S2 1.18 94 H17 413.5 4.34 5 0 N-(2-oxonaphtho[2,1-d][1,3]oxathiol-5-yl)-N-tosylacetamide

Primary screening of 17,700 small molecules identified 83 inhibitors of the cAMP-induced redistribution of AQP2 in MCD4 cells. Secondary screening revealed that 17 chemically highly diverse hits inhibited the AQP2 redistribution in a concentration-dependent manner in MCD4 cells (compounds 1–17). Compounds 1–5 also inhibited the redistribution in IMCD cells. Compounds are ranked according to increasing ratios of plasma membrane/intracellular AQP2 fluorescence signal intensities. Compounds with ratios ≤ 1.2 were defined as inhibitory (a predominant intracellular localization of AQP2). Compound ID numbers (ID), compound library positions (plate, well), molecular weight, numbers of proton donor (H-Don.) and acceptor (H-Acc.) moieties are given for each substance. Compound names are according to the International Union of Pure and Applied Chemistry nomenclature. IUPAC, International Union of Pure and Applied Chemistry.